References
- Smyth EC, Lagergren J, Fitzgerald RC, et al. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. doi:https://doi.org/10.1038/nrdp.2017.48
- Pickens A, Orringer MB. Geographical distribution and racial disparity in esophageal cancer. Ann Thorac Surg. 2003;76(4):S1367–S1369. doi:https://doi.org/10.1016/S0003-4975(03)01202-5.
- Alakus H, Holscher AH, Grass G, et al. Extracapsular lymph node spread: a new prognostic factor in gastric cancer. Cancer. 2010;116(2):309–315. doi:https://doi.org/10.1002/cncr.24764.
- An Y, Park HS, Kelly JR, et al. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. 2017;123(14):2762–2772. doi:https://doi.org/10.1002/cncr.30598
- Aziz S, Wik E, Knutsvik G, et al. Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. PLoS One. 2017;12(2):e0171853. doi:https://doi.org/10.1371/journal.pone.0171853
- Bauer E, Mazul A, Chernock R, et al. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma. Laryngoscope. 2020;130(4):939–945. doi:https://doi.org/10.1002/lary.28059
- Nottegar A, Veronese N, Senthil M, et al. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: a systematic review and an exploratory meta-analysis. Eur J Surg Oncol. 2016;42(7):919–925. doi:https://doi.org/10.1016/j.ejso.2016.02.259.
- Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012;22(11):1144–1152. doi:https://doi.org/10.1089/thy.2012.0043.
- Wind J, ten Kate FJ, Kiewiet JJ, et al. The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer. Eur J Surg Oncol. 2008;34(4):390–396. doi:https://doi.org/10.1016/j.ejso.2007.05.011.
- James DB, Christian W. TNM classification of malignant tumors. 8th ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2017.
- D’Journo XB, Avaro JP, Michelet P, et al. Extracapsular lymph node involvement is a negative prognostic factor after neoadjuvant chemoradiotherapy in locally advanced esophageal cancer. J Thorac Oncol. 2009;4(4):534–539. doi:https://doi.org/10.1097/JTO.0b013e31819c862d.
- Luchini C, Wood LD, Cheng L, et al. Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis. J Clin Pathol. 2016;69(11):956–961. doi:https://doi.org/10.1136/jclinpath-2016-203830.
- Metzger R, Bollschweiler E, Drebber U, et al. Neoadjuvant chemoradiotherapy for esophageal cancer: impact on extracapsular lymph node involvement. World J Gastroenterol. 2010;16(16):1986–1992. doi:https://doi.org/10.3748/wjg.v16.i16.1986
- Nafteux PR, Lerut AM, Moons J, et al. International multicenter study on the impact of extracapsular lymph node involvement in primary surgery adenocarcinoma of the esophagus on overall survival and staging systems. Ann Surg. 2015;262(5):809–815 (Nov discussion 815–6). doi:https://doi.org/10.1097/SLA.0000000000001463.
- Okada N, Daiko H, Kanamori J, et al. Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinoma. Surgery. 2019;165(6):1203–1210. doi:https://doi.org/10.1016/j.surg.2018.12.017.
- Sakai M, Suzuki S, Sano A, et al. Significance of lymph node capsular invasion in esophageal squamous cell carcinoma. Ann Surg Oncol. 2012;19(6):1911–1917. doi:https://doi.org/10.1245/s10434-012-2232-7
- Tanabe T, Kanda T, Kosugi S, et al. Extranodal spreading of esophageal squamous cell carcinoma: clinicopathological characteristics and prognostic impact. World J Surg. 2007;31(11):2192–2198. doi:https://doi.org/10.1007/s00268-007-9204-2
- D’Annoville T, D’Journo XB, Loundou A, et al. Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System. Eur J Cardiothorac Surg. 2013;44(3):e207–11 (Sep discussion e211). doi:https://doi.org/10.1093/ejcts/ezt332.
- Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus. 2019;16(1):25–43. doi:https://doi.org/10.1007/s10388-018-0642-8
- Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus. 2019;16(1):1–24. doi:https://doi.org/10.1007/s10388-018-0641-9
- Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi:https://doi.org/10.1097/SLA.0b013e3181b13ca2.
- Katayama H, Kurokawa Y, Nakamura K, et al. Extended Clavien–Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46(6):668–685. doi:https://doi.org/10.1007/s00595-015-1236-x
- Griffin S, Shaw IH, Dresner SM. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy risk factors and management. Am Coll Surg. 2002;194(3):286–297.
- Weijs TJ, Berkelmans GH, Nieuwenhuijzen GA, et al. Routes for early enteral nutrition after esophagectomy. A systematic review. Clin Nutr. 2015;34(1):1–6. doi:https://doi.org/10.1016/j.clnu.2014.07.011
- Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19(1):68–74. doi:https://doi.org/10.1245/s10434-011-2049-9